FROM HOPE TRIAL TO ONTARGET TRIAL: THE «HOPE» TO REACH THE «TARGET» - TO IMPROVE PROGNOSIS IN HIGH RISK PATIENTS

Results of HOPE trial are analyzed. It is noted, that treatment with angiotensine converting enzyme inhibitor (iACE) ramipril improves the prognosis in high risk cardio-vascular patients. The objectives and study design of ONTARGET/TRANSCEND trials are introduced. Perspectives of joint use of ACE in...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yazar: Yu. M. Lopatin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Stolichnaya Izdatelskaya Kompaniya 2016-01-01
Seri Bilgileri:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Konular:
high cardio-vascular risk
ramipril
telmisartan
норе trial
ontarget trial
Online Erişim:https://www.rpcardio.com/jour/article/view/1052
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller